Article
STRA6 regulates tumor immune microenvironment and is a prognostic marker in BRAF-mutant papillary thyroid carcinoma
10 Feb 2023
Abstract excerpt
Background BRAF mutation is one of the most common genetic alterations contributing to the initiation and progression of papillary thyroid carcinoma (PTC). However, the prognostic value of BRAF mutation for PTC is limited. Novel markers are needed to identify BRAF-mutant patients with poor prognosis. Methods Transcriptional expression data were downloaded from the Cancer Genome Atlas (TCGA) and Gene Expression...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
